Lemaitre Vascular LMAT
NASDAQ LMAT
$80.19 -2.40 (-2.91%)
At close: Oct 1, 2026 · 4:00 PM EDT

Lemaitre Vascular (LMAT) Income from Continuing Operations (2010 - 2026)

Updated

Lemaitre Vascular (LMAT) reported Income from Continuing Operations of $17.05 million for Q2 2026, up 23.7% from $13.78 million a year earlier and up 8.7% from the prior quarter.

Analysis

Lemaitre Vascular (LMAT) Income from Continuing Operations (2010 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Lemaitre Vascular's Income from Continuing Operations came in at $65.67 million, up 39.4% year-over-year; for FY2025, it was $57.73 million, up 31.1% from FY2024.

  • Income from Continuing Operations has increased for three consecutive years, with a five-year compound annual growth rate of 22.2% (FY2020 to FY2025).
  • By year, Income from Continuing Operations came in at $44.04 million in FY2024 (+46.3%), $30.11 million in FY2023 (+45.9%), $20.64 million in FY2022 (-23.3%) and $26.91 million in FY2021 (+26.8%).
  • Five-year quarterly Income from Continuing Operations spans a low of $3.52 million in Q2 2022 and a high of $17.36 million in Q3 2025.
  • Year over year, Income from Continuing Operations has now increased in each of the last 13 quarters, with growth averaging 33.7% over the last eight quarters.
  • The high point for year-over-year Income from Continuing Operations in five years was Q2 2023 (growth of 130.4%); the low point was Q2 2022 (a decline of 57.6%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $15.68 million (Q1 2026), $15.58 million (Q4 2025) and $17.36 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 1.76 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 928.00 Mn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 870.00 Mn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn 823.20 Mn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 1.48 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn -220.00 Mn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 905.00 Mn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 241.40 Mn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 451.00 Mn
10 Lemaitre Vascular 1.89 Bn 442.77 Mn 50.76 Mn 17.05 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17.05 Mn
Mar 31, 2026 15.68 Mn
Dec 31, 2025 15.58 Mn
Sep 30, 2025 17.36 Mn
Jun 30, 2025 13.78 Mn
Mar 31, 2025 11.01 Mn
Dec 31, 2024 11.18 Mn
Sep 30, 2024 11.14 Mn
Jun 30, 2024 11.83 Mn
Mar 31, 2024 9.89 Mn
Dec 31, 2023 8.47 Mn
Sep 30, 2023 7.50 Mn
Jun 30, 2023 8.10 Mn
Mar 31, 2023 6.04 Mn
Dec 31, 2022 5.63 Mn
Sep 30, 2022 5.46 Mn
Jun 30, 2022 3.52 Mn
Mar 31, 2022 6.04 Mn
Dec 31, 2021 6.18 Mn
Sep 30, 2021 6.50 Mn
API Access

Lemaitre Vascular Income from Continuing Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=LMAT&period=max&api_key=YOUR_API_KEY